Skip to main content
. Author manuscript; available in PMC: 2022 Mar 7.
Published in final edited form as: ACS Appl Bio Mater. 2021 Sep 24;4(10):7708–7718. doi: 10.1021/acsabm.1c00961

Figure 4.

Figure 4.

Cell viability of (a) MCF-7 cells upon dosage with varying concentrations of combination INMs and parent compounds (0.5–20 μM) for 24 h and (b) FA-coated INMs incubated in cancer (MCF-7) and noncancerous (MCF-10A) cell lines for 24 h at a concentration range of 0.5–10 μM (*p < 0.05, **p < 0.01, ***p < 0.005).